Martin Duplessis

Martin Duplessis is a Senior Scientist at Repare Therapeutics since January 2022, previously serving as a Senior Research Scientist at C4 Therapeutics, Inc. from April 2016 to November 2021, focusing on the design and synthesis of heterobifunctional molecules for targeted protein degradation. Prior experience includes a role as a Scientist at Constellation Pharmaceuticals from January 2013 to April 2016, where the emphasis was on the discovery of small molecule inhibitors for epigenetic targets and the synthesis of biologically active compounds. Martin also contributed to drug discovery projects in virology as a Research Associate at Boehringer Ingelheim (Canada) Ltd. from October 2005 to December 2012. Educational credentials include a Master of Science in Organic Chemistry from Université de Montréal (2003-2006) and a Bachelor of Science in Chemistry from McGill University (2000-2003).